Ironwood Pharmaceuticals, Inc.

Symbol: IRWD

NASDAQ

6.74

USD

Market price today

  • -1.0492

    P/E Ratio

  • 0.1032

    PEG Ratio

  • 1.07B

    MRK Cap

  • 0.00%

    DIV Yield

Ironwood Pharmaceuticals, Inc. (IRWD) Financial Statements

On the chart you can see the default numbers in dynamics for Ironwood Pharmaceuticals, Inc. (IRWD). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Ironwood Pharmaceuticals, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

092.2656.2620.1
362.6
177
173.2
221.4
305.2
439.4
248.3
197.6
168.2
164
248
123.1
89.8
91.9

balance-sheet.row.short-term-investments

0000
0
0
0
95.7
251.2
178.1
174
122.1
31.5
76.7
203.7
0
22
29.5

balance-sheet.row.net-receivables

0129.1115.5114
122.4
117.2
81
82.2
64.9
54.5
25.8
3.2
1.5
0.7
2.9
5.2
7.1
25.5

balance-sheet.row.inventory

001.31.3
0
0.6
0
0.7
1.1
0
5
22.1
6.7
0
-239.9
0
2.5
0

balance-sheet.row.other-current-assets

0127.79.8
9.2
11.9
12.3
7.3
9
6.3
10.6
6.2
8
2.9
248
3.1
8.7
1.7

balance-sheet.row.total-current-assets

0233.3780.6745.2
495.8
306.9
266.4
311.6
380.2
500.2
289.7
229.1
184.4
167.6
259.1
131.4
108.1
119.2

balance-sheet.row.property-plant-equipment-net

018.220.322.9
25.5
30.2
17.3
17.3
20.5
21.1
29.8
37.4
37.5
33.6
34.4
22.6
24.6
4.1

balance-sheet.row.goodwill

0000
0.8
0.8
0.8
0.8
0.8
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

03.700
0
0
0
159.9
166.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

03.7-15.1-24.5
0.8
0.8
0.8
160.7
166.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0015.124.5
37
64.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0212.3283.7333.3
-37
-64.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

03.615.925.5
37.1
64.9
47.6
116.1
142.2
97.8
14
12.5
7.9
7.8
7.9
8.5
8
12.6

balance-sheet.row.total-non-current-assets

0237.8319.9381.7
63.4
95.9
65.6
294.1
329.6
118.9
43.8
49.8
45.5
41.4
42.3
31
32.6
16.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0471.11100.51126.9
559.2
402.7
332.1
605.7
709.8
619.1
333.5
279
229.9
209
301.4
162.5
140.7
135.9

balance-sheet.row.account-payables

07.80.50.9
0.7
5.5
71.6
61.5
62.9
36.1
35.9
32
48.6
6.4
21.4
4.9
6.1
5.6

balance-sheet.row.short-term-debt

0202.73.1120
3.1
1.1
47.6
4.1
6.2
27.6
12.4
1.1
0.3
0.2
0.2
1.5
1.1
1

balance-sheet.row.tax-payables

01.20.70.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0498.3412.9355.8
450.6
430.1
366.3
396.1
366.6
353.9
164.9
177.8
0.3
0.4
0.4
1.9
1.1
2

Deferred Revenue Non Current

0000
0
0
0
0
0
1.8
9
11.4
18
21.1
77
104.1
48.2
58.6

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

064.3221.3
0.5
33.4
0.1
0.2
14.2
5.5
5
2.8
2.7
22.2
0
17.3
14
7.5

balance-sheet.row.total-non-current-liabilities

0541.3422.6359.3
463.9
455.1
408.9
529.8
552
447.5
184.4
199.7
30.9
34
77.4
404.4
332
284.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

014.519.721.6
23.4
23.2
0.2
4.1
6.3
2.9
3.7
4.3
0.6
0.7
0.6
0.3
0.3
0

balance-sheet.row.total-liab

0817.4448.1521
496.6
496
528.4
595.8
643.1
524
245
240.7
85.9
99.1
141.8
460.8
371.1
314.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
298.4
0
0

balance-sheet.row.common-stock

00.20.20.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0

balance-sheet.row.retained-earnings

0-1698.6-696.4-937.6
-1466.1
-1572.2
-1591.1
-1308.8
-1191.8
-1110.1
-967.4
-777.8
-505
-432.4
-367.5
-314.6
-243.4
-189.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-300
0
0
0
-0.1
0
-0.1
0
0
0
0
0
-298.4
0
0

balance-sheet.row.other-total-stockholders-equity

01355.21348.61543.4
1528.5
1478.8
1394.6
1318.5
1258.4
1205.2
1055.9
815.9
649
542.1
527
13
7.6
4.6

balance-sheet.row.total-stockholders-equity

0-346.3652.4605.9
62.6
-93.3
-196.4
9.8
66.7
95.1
88.6
38.2
144.1
109.9
159.6
-301.6
-235.8
-184.9

balance-sheet.row.total-liabilities-and-stockholders-equity

0471.11100.51126.9
559.2
402.7
332.1
605.7
709.8
619.1
333.5
279
229.9
209
301.4
162.5
140.7
135.9

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
3.2
5.3
6.5

balance-sheet.row.total-equity

0-346.3652.4605.9
62.6
-93.3
-196.4
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0015.124.5
37
64.9
0
95.7
251.2
178.1
174
122.1
31.5
76.7
203.7
0
22
29.5

balance-sheet.row.total-debt

0715.5415.9475.8
453.7
431.2
413.9
400.2
372.8
381.5
177.3
178.9
0.6
0.7
0.6
3.3
2.1
3

balance-sheet.row.net-debt

0623.4-240.3-144.3
91.1
254.2
240.8
274.4
318.8
120.2
103
103.5
-136.1
-86.6
-43.7
-119.8
-65.6
-59.5

Cash Flow Statement

The financial landscape of Ironwood Pharmaceuticals, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

0-1002.2175.1528.4
106.2
21.5
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.9
-56.4
-73.3
-55
-53.2

cash-flows.row.depreciation-and-amortization

01.61.41.5
3.6
5.6
14.2
14.6
11.3
11.6
12.3
11.7
11.3
10
6.2
5.3
2.8
1.7

cash-flows.row.deferred-income-tax

072.665.7-333.3
6.6
35.9
159.1
7.5
-7.3
28.5
21.5
1.9
0
0
-5.5
1
0
0

cash-flows.row.stock-based-compensation

0322722.3
31.2
31.3
44
33.8
29.2
25.5
26.2
19.8
17.6
11.7
7.5
5.2
2.8
1.2

cash-flows.row.change-in-working-capital

011.32.817.7
-0.9
-100
7.6
-21.8
-5
-38.2
-30.1
-35.7
-27.1
-34.4
-21.3
58.2
20.7
45.2

cash-flows.row.account-receivables

00.987.7
4.1
-68.9
1.2
-17.3
-10.3
-28.7
-23.7
-1.7
-0.8
2.2
2.3
-0.5
18.4
-24.3

cash-flows.row.inventory

0000
0.6
0.7
-0.8
0.3
1.3
3.7
-3.1
-11.9
-6.7
1.3
-9.3
1.7
0
0

cash-flows.row.account-payables

012.4-8.1-2.6
-7.5
-32.7
8.1
-6.8
19.7
-1.6
1.4
-11.7
24.2
5.1
2.7
1.6
0
0

cash-flows.row.other-working-capital

0-22.912.7
1.8
0.9
-0.8
2
-15.6
-11.7
-4.8
-10.3
-43.8
-43
-17.1
55.4
2.3
69.5

cash-flows.row.other-non-cash-items

01068.21.725.2
22.3
16.4
-13.4
-16.8
28.1
8.4
4.1
1.7
1.2
2.2
1.6
-0.4
0.5
-1.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.3-0.1-0.3
-1.8
-7.2
-8.6
-4.2
-104.2
-4
-3.5
-9.6
-14
-9.7
-17.2
-4
-22.9
-2.7

cash-flows.row.acquisitions-net

0-102600
0
0.3
0
0
100
0
0
0
0
0
9.5
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
-3.2
-191.4
-311.1
-282
-254
-287.9
-96.7
-97.5
-441.8
-26.7
-82.6
-87.8

cash-flows.row.sales-maturities-of-investments

0000
0
0
99.2
346.9
237.4
276.7
201
196.1
140.8
222.3
236.5
48.5
90.5
62.9

cash-flows.row.other-investing-activites

0000
0
-4.2
1.6
0.1
-99.8
0.1
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-1026.3-0.1-0.3
-1.8
-11.1
88.9
151.5
-177.7
-9.2
-56.6
-101.4
30.1
115.1
-213
17.8
-15.1
-27.6

cash-flows.row.debt-repayment

0-300-120.70
0
-156.4
-1.8
-137.5
-28.8
-14
-2.2
-0.8
-0.3
-0.3
-2
-1.5
-1.7
-0.9

cash-flows.row.common-stock-issued

06.49.519.6
18.5
13.6
0
0
0
0
190.4
137.8
85.2
0
203.2
40.3
0
0

cash-flows.row.common-stock-repurchased

00-126.4-24.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-111.20
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0570.8111.2-4.5
18.5
141.6
31.9
157.3
24.6
317.1
22.7
176.6
4
3.4
1.7
2.9
50.2
51.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0277.2-237.6-4.5
18.5
-1.2
30.1
19.8
-4.2
303.1
210.9
313.6
89
3.1
203
41.7
48.6
50.7

cash-flows.row.effect-of-forex-changes-on-cash

0-0.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-565.336.1257.1
185.5
-1.6
48.1
71.7
-207.3
187
-1.2
-61.2
49.4
43
-78
55.4
5.3
16.4

cash-flows.row.cash-at-end-of-period

092.2657.9621.9
364.8
179.2
180.8
125.7
54
261.3
74.3
75.5
136.7
87.3
44.3
123.1
67.7
62.4

cash-flows.row.cash-at-beginning-of-period

0657.5621.9364.8
179.2
180.8
132.8
54
261.3
74.3
75.5
136.7
87.3
44.3
122.3
67.7
62.4
46.1

cash-flows.row.operating-cash-flow

0183.4273.8261.9
168.8
10.7
-70.9
-99.6
-25.4
-106.9
-155.6
-273.4
-69.6
-75.2
-67.9
-4
-28.2
-6.8

cash-flows.row.capital-expenditure

0-0.3-0.1-0.3
-1.8
-7.2
-8.6
-4.2
-104.2
-4
-3.5
-9.6
-14
-9.7
-17.2
-4
-22.9
-2.7

cash-flows.row.free-cash-flow

0183.2273.6261.6
167
3.5
-79.5
-103.8
-129.6
-111
-159.1
-282.9
-83.6
-84.9
-85.1
-8
-51.1
-9.4

Income Statement Row

Ironwood Pharmaceuticals, Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of IRWD is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

0442.7410.6413.8
389.5
428.4
346.6
298.3
274
149.6
76.4
22.9
150.2
65.9
43.9
36.1
22.2
10.5

income-statement-row.row.cost-of-revenue

01.61.41.5
3.1
23.9
32.8
19.4
1.9
0
25.6
7.2
1
0
0
0
0
0

income-statement-row.row.gross-profit

0441.2409.2412.2
386.4
404.5
313.9
278.9
272.1
149.5
50.9
15.7
149.3
65.9
43.9
36.1
22.2
10.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0.5
8.1
6.2
1
17.6
0.7
42.1
16
0
0
24
18.3
10.8

income-statement-row.row.operating-expenses

0232.1160.3181.5
228.1
287.5
415.9
387.6
313.8
234
220.2
267.7
222
132
104.6
108.9
78.1
68.1

income-statement-row.row.cost-and-expenses

0233.7160.3181.5
231.2
311.4
448.7
407
315.6
234
245.8
274.9
223
132
104.6
108.9
78.1
68.1

income-statement-row.row.interest-income

0199.50.7
1.5
2.9
3
2.1
1.2
0.4
0.3
0.2
0.2
0.5
0.6
0.2
2.1
4.1

income-statement-row.row.interest-expense

021.67.631.1
29.5
36.6
34.7
34.3
38
30.7
21.2
21
0.1
0.1
0.2
0.5
0.3
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1157.12.1-31.6
-34.1
-61.2
-145.6
26
-2.1
-27.6
0.7
-20.8
0.1
0.9
1.4
-0.6
-0.9
0.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0.5
8.1
6.2
1
17.6
0.7
42.1
16
0
0
24
18.3
10.8

income-statement-row.row.total-operating-expenses

0-1157.12.1-31.6
-34.1
-61.2
-145.6
26
-2.1
-27.6
0.7
-20.8
0.1
0.9
1.4
-0.6
-0.9
0.6

income-statement-row.row.interest-expense

021.67.631.1
29.5
36.6
34.7
34.3
38
30.7
21.2
21
0.1
0.1
0.2
0.5
0.3
0.3

income-statement-row.row.depreciation-and-amortization

01.69.50.7
16.9
0.3
8.1
6.2
1
11.6
12.3
11.7
11.3
10
6.2
5.3
2.8
1.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0209250.3232.3
142.9
120.1
-238.9
-77.4
-51.9
-102.1
-169.4
-252
-72.8
-66.1
-60.8
-72.8
-55.9
-57.6

income-statement-row.row.income-before-tax

0-948.1252.4200.7
108.9
58.9
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.8
-59.4
-73.6
-55
-53.2

income-statement-row.row.income-tax-expense

083.577.4-327.8
2.7
74.3
-5.8
34.3
38
19
8.6
-11.7
-11.3
0
-2.9
-0.3
-0.8
-0.1

income-statement-row.row.net-income

0-1002.2175.1528.4
106.2
-15.3
-282.4
-116.9
-81.7
-142.7
-189.6
-272.8
-72.6
-64.9
-53
-71.2
-53.9
-52.8

Frequently Asked Question

What is Ironwood Pharmaceuticals, Inc. (IRWD) total assets?

Ironwood Pharmaceuticals, Inc. (IRWD) total assets is 471073000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.996.

What is company free cash flow?

The free cash flow is 1.174.

What is enterprise net profit margin?

The net profit margin is -2.264.

What is firm total revenue?

The total revenue is -2.120.

What is Ironwood Pharmaceuticals, Inc. (IRWD) net profit (net income)?

The net profit (net income) is -1002239000.000.

What is firm total debt?

The total debt is 715538000.000.

What is operating expences number?

The operating expences are 232124000.000.

What is company cash figure?

Enretprise cash is 0.000.